The Centers for Medicare & Medicaid Services today announced the extension of its Appropriate Use Criteria testing period through 2021.

This means the AUC program will not impact claims for diagnostic imaging services until Jan. 1, 2022, at the earliest.

The AHA has long advocated for an extension, including most recently in an AHA and American Medical Association joint letter in July. The letter stressed how the COVID-19 public health emergency has resulted in reduced imaging services, adding financial strains and prohibiting providers from sufficiently engaging in the AUC program’s preparatory steps; therefore, AHA is pleased to see CMS implement a delay to this program.

Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…